Acadia Pharmaceuticals reported $640.92M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
ALKERMES ALKS:US 1.05B 15.25M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Aptinyx Inc APTX:US $ 132.41M 1.37M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cara Therapeutics CARA:US $ 171.5M 7.03M
Corcept Therapeutics CORT:US $ 401.9M 9.37M
Cytokinetics CYTK:US $ 494.94M 130.71M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Moderna Inc MRNA:US 13.42B 2.46B
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Prothena PRTA:US 607.53M 198.06M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vanda Pharmaceuticals VNDA:US $ 461.81M 15.16M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
YTE INCY:US $ 2923.8M 303.74M
Zogenix ZGNX:US $ 375.46M 40.93M